Manufacturer of Controlled Substances; Notice of Registration

[Federal Register Volume 64, Number 161 (Friday, August 20, 1999)]
[Notices]
[Page 45565]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-21584]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated February 5, 1999, and published in the Federal 
Register on February 26, 1999, (64 FR 9541), Medeva Pharmaceuticals CA, 
Inc., 3501 West Garry Avenue, Santa Ana, California 92704, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Methylphenidate (1724).....................  II
Diphenoxylate (9170).......................  II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances to 
make finished dosage forms for distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Medeva Pharmaceuticals CA, Inc. to 
manufacture the listed controlled substances is consistent with the 
public interest at this time. DEA has investigated Medeva 
Pharmaceuticals CA, Inc. on a regular basis to ensure that the 
company's continued registration is consistent with the public 
interest. These investigations have included inspection and testing of 
the company's physical security systems, audits of the company's 
records, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy 
Assistant Administrator, Office of Diversion Control, hereby orders 
that the application submitted by the above firm for registration as a 
bulk manufacturer of the basic classes of controlled substances listed 
above is granted.

    Dated: August 5, 1999.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 99-21584 Filed 8-19-99; 8:45 am]
BILLING CODE 4410-09-M